197 related articles for article (PubMed ID: 21163532)
1. Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.
Sharp JA; Cunnion KM
Mol Immunol; 2011 Jan; 48(4):683-90. PubMed ID: 21163532
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic.
Sharp JA; Echague CG; Hair PS; Ward MD; Nyalwidhe JO; Geoghegan JA; Foster TJ; Cunnion KM
PLoS One; 2012; 7(5):e38407. PubMed ID: 22675461
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
Cunnion KM; Hair PS; Buescher ES
Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
[TBL] [Abstract][Full Text] [Related]
6. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
[TBL] [Abstract][Full Text] [Related]
7. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
[TBL] [Abstract][Full Text] [Related]
9. A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.
Sage MAG; Cranmer KD; Semeraro ML; Ma S; Galkina EV; Tran Y; Wycoff KL; Sharp JA
PLoS One; 2022; 17(3):e0265774. PubMed ID: 35324969
[TBL] [Abstract][Full Text] [Related]
10. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum.
Friberg N; Carlson P; Kentala E; Mattila PS; Kuusela P; Meri S; Jarva H
J Immunol; 2008 Dec; 181(12):8624-32. PubMed ID: 19050282
[TBL] [Abstract][Full Text] [Related]
11. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization.
Hair PS; Wagner SM; Friederich PT; Drake RR; Nyalwidhe JO; Cunnion KM
Mol Immunol; 2012 Apr; 50(4):253-61. PubMed ID: 22333221
[TBL] [Abstract][Full Text] [Related]
12. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
13. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).
Bexborn F; Andersson PO; Chen H; Nilsson B; Ekdahl KN
Mol Immunol; 2008 Apr; 45(8):2370-9. PubMed ID: 18096230
[TBL] [Abstract][Full Text] [Related]
14. Hijacking Factor H for Complement Immune Evasion.
Moore SR; Menon SS; Cortes C; Ferreira VP
Front Immunol; 2021; 12():602277. PubMed ID: 33717083
[TBL] [Abstract][Full Text] [Related]
15. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
[TBL] [Abstract][Full Text] [Related]
16. Capsule production and growth phase influence binding of complement to Staphylococcus aureus.
Cunnion KM; Lee JC; Frank MM
Infect Immun; 2001 Nov; 69(11):6796-803. PubMed ID: 11598052
[TBL] [Abstract][Full Text] [Related]
17. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
Cunnion KM; Buescher ES; Hair PS
J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
[TBL] [Abstract][Full Text] [Related]
18. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
Garcia BL; Ramyar KX; Tzekou A; Ricklin D; McWhorter WJ; Lambris JD; Geisbrecht BV
J Mol Biol; 2010 Sep; 402(1):17-29. PubMed ID: 20654625
[TBL] [Abstract][Full Text] [Related]
20. A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors.
Paixão-Cavalcante D; Torreira E; Lindorfer MA; Rodriguez de Cordoba S; Morgan BP; Taylor RP; Llorca O; Harris CL
J Immunol; 2014 May; 192(10):4844-51. PubMed ID: 24729617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
